Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 08, 2015 2:38 PM ET

Healthcare Equipment and Supplies

Company Overview of IMRIS, Inc.

Company Overview

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovas...

100-1370 Sony Place

Winnipeg, MB R3T 1N5


Founded in 2005

121 Employees





Key Executives for IMRIS, Inc.

Chief Executive Officer, President, Director and Member of Strategic Committee
Age: 55
Total Annual Compensation: $450.0K
Principal Accounting Officer and Director of Finance
Total Annual Compensation: $160.0K
Executive Vice President of Operations
Total Annual Compensation: $250.0K
Chief Technology Officer and Executive Vice President of Research & Development
Total Annual Compensation: $285.0K
Compensation as of Fiscal Year 2014.

IMRIS, Inc. Key Developments

Nasdaq To File Form 25 To Delist Common Stock Of Imris

The Nasdaq Stock Market announced that it will delist the common stock of Imris Inc. Imris Inc’s stock was suspended on June 4, 2015 and has not traded on Nasdaq since that time. Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for the company. The delisting become effective ten days after the Form 25 is filed.

IMRIS, Inc.(NasdaqGS:IMRS) dropped from NASDAQ Composite Index

IMRIS, Inc. will be removed from Nasdaq Composite Index.

TSX Determines To Delist Common Shares Of IMRIS

Further to TSX Bulletin 2015-0549 dated May 26, 2015, TSX has determined to delist the common shares of IMRIS Inc. at the close of business on July 2, 2015 for failure to meet the continued listing requirements of TSX. The common shares will remain suspended from trading.

Similar Private Companies By Industry

Company Name Region
Functional Neuromodulation, Ltd. Americas
Sentio Life Solutions Ltd. Americas
Product Design Group, Inc. Americas
Kardium Inc. Americas
Vimedix Virtual Medical Imaging Training Systems, Inc. Americas

Recent Private Companies Transactions

May 25, 2015
IMRIS, Inc. And NeuroArm Surgical Limited
Private Placement
December 22, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMRIS, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at